Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-27

Clinical Trial Update: Perceval Sutureless Implant Versus Standard-Aortic Valve Replacement [NA]

View source ↗

Summary

A terminated clinical trial comparing Perceval sutureless aortic valve replacement with standard AVR; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Perceval (sutureless aortic valve replacement)

Snippet

Sponsor: Corcym S.r.l | Conditions: Aortic Valve Disease, Aortic Stenosis | NA | Status: TERMINATED | Results posted: 2022-07-27